Penn engineers develop AI tool to design peptides that turn signals on or off - EurekAlert!
Penn engineers have developed an AI tool to design peptides that can turn signals on or off. This tool has the potential to revolutionize the field of bioengineering.
- Penn engineers have developed an AI tool to design peptides that can turn signals on or off
- The tool uses machine learning algorithms to design peptides with specific functions
- The technology has the potential to be used in a variety of applications, including the development of new treatments for diseases
- The tool could accelerate the development of new treatments by allowing for the rapid design and testing of new peptides
The AI tool, developed by Penn engineers, uses machine learning algorithms to design peptides that can bind to specific targets and turn signals on or off. This technology has the potential to be used in a variety of applications, including the development of new treatments for diseases.
The tool works by analyzing the structure and function of existing peptides and using this information to design new peptides with specific properties. This approach allows for the rapid design and testing of new peptides, which could accelerate the development of new treatments.
The development of this tool is a significant breakthrough in the field of bioengineering, as it could enable the creation of new therapies and treatments that are more targeted and effective.
The use of AI in peptide design is a growing area of research, and this tool is an example of the potential of this technology to drive innovation in the field.
could lead to new tools and technologies for bioengineering
could lead to new treatments and therapies
could lead to new investment opportunities in the field of bioengineering
could lead to new areas of research and study
could lead to new treatments and therapies for a variety of diseases
- peptides
- short chains of amino acids that can bind to specific targets and perform specific functions
Natural traces in forensic investigations: Integrating biological trace analysis and artificial intelligence in forensic investigations - Open Access Government
UN digital tech agency launches initiative to improve trust in AI agents - Reuters
AI ResearchLoop Engineering for Hierarchical Retrieval: Reading a Long Document by Its Table of Contents
AI ResearchOpenAI finds roughly 30 percent of popular AI coding test is broken
AI ResearchLarge Tabular Models Excel Where LLMs Fail
AI ToolsCharacter.AI wants a piece of the microdrama pie
Character.AI launches c.ai Series, a new platform for AI-generated animated microdramas designed for vertical video. The move targets a rapidly growing $26 billion market.
Over-the-top AI campaign ads will test Oregon disclosure law - Oregon Public Broadcasting - OPB
Oregon’s new law requiring disclosure of AI-generated campaign ads will face its first real test as over-the-top political ads flood the state.
AI ToolsGeForce NOW Turns Up the Heat With New GeForce RTX 5080-Powered Toronto Server
Nvidia's GeForce NOW cloud gaming service expands to Toronto with a new server powered by GeForce RTX 5080 graphics cards.
AI ToolsCharacter.ai enters the microdrama arena with its own productions, but with a twist
Character AI is expanding beyond chatbots by producing short-form interactive dramas where users can converse with characters and shape storylines in real time.
FundingPopular open source AI developer tool Ollama raises $65M, grows to nearly 9M users
Ollama, a popular open-source AI tool for running models locally, raised $65 million and now has nearly 9 million users. The platform has also gained significant traction on GitHub with over 176,000 stars.
Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai - Fierce Healthcare
Viz.ai has partnered with Cortechs.ai to expand AI-driven care for neurodegenerative diseases, leveraging advanced imaging and clinical decision support tools.